8-KLeadership Changes

AbbVie Inc. 8-K Report, Executive Changes (Dec 13, 2024)

Filed December 13, 2024For Securities:ABBV

Summary

This 8-K filing from AbbVie Inc. announces a key executive transition within its finance department. Kevin K. Buckbee, Senior Vice President and Controller, has indicated his planned retirement effective March 1, 2025. This marks the end of Mr. Buckbee's tenure in the Controller role, and the company has appointed David R. Purdue to succeed him. Mr. Purdue, currently Vice President, Controller, Commercial Operations, brings extensive experience within AbbVie and its former parent, Abbott Laboratories. His appointment as Senior Vice President, Controller will be effective on the same date as Mr. Buckbee's retirement. Investors should note Mr. Purdue's new compensation package, including a base salary of $550,000 and eligibility for a performance-based bonus plan, reflecting the importance of this role in financial oversight and strategy.

Key Highlights

  • 1Kevin K. Buckbee, Senior Vice President and Controller, plans to retire effective March 1, 2025.
  • 2David R. Purdue appointed as the new Senior Vice President, Controller, effective March 1, 2025.
  • 3Mr. Purdue has a long history with AbbVie and Abbott Laboratories, holding various finance leadership roles.
  • 4Mr. Purdue's new annual base salary will be $550,000.
  • 5Mr. Purdue is eligible for a performance-based bonus plan with a target bonus of 85% of his base salary.
  • 6The filing is classified as an 8-K Current Report, signaling a material event.

Frequently Asked Questions

David R. Purdue has been appointed as the new Senior Vice President, Controller, effective March 1, 2025. Mr. Purdue has held several finance leadership positions within AbbVie, including Vice President, Controller, Commercial Operations since 2022.

The transition will be effective on March 1, 2025. This is when Kevin K. Buckbee will retire from his Controller role, and David R. Purdue will assume the position.

As Senior Vice President, Controller, Mr. Purdue's annual base salary will be $550,000. He will also be eligible to participate in AbbVie's Performance Incentive Plan or a successor plan, with a target bonus of 85% of his base salary, contingent upon achieving performance targets.

While executive departures and appointments are routine in large companies, this filing is an 8-K, which is used to report any major event that shareholders should be aware of. The retirement of a Senior Vice President and Controller and the appointment of a successor is considered a material event requiring disclosure.